Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 03, 2021 8:45 AM - Nov 05, 2021 1:15 PM

(Central Europe Standard Time)

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

15th Anniversary

Session 3: QPPV Requirements And Expectations In Non-Eu Countries

Session Chair(s)

Shahinaz  Badr

Shahinaz Badr

Pharmacovigilance Consultant and PVQA Auditor - EMEA

Pharma Quality Europe, United Arab Emirates

Willemijn  van der Spuij, MSc

Willemijn van der Spuij, MSc

Executive Director, WorldWide Patient Safety International, Europe

Switzerland

Over the years global development of QPPV requirements have been implemented. We will address multiple regions and countries to identify the different local requirements implemented and how does this affect the PV system. Differences and similarities of the requirements and responsibilities for non-EU QPPV and EU QPPV will be explored including high level consideration of:

  • how this will influence or impact the EU QPPV
  • Opportunities and Challenges in the oversight

Leading to session 4: You by now well informed on the requirements so let us explore how can we implement those requirements in the PV system through session 4.

Speaker(s)

Willemijn  van der Spuij, MSc

Presentation covering Europe (Turkey, Serbia, Switzerland)

Willemijn van der Spuij, MSc

Switzerland

Executive Director, WorldWide Patient Safety International, Europe

Moonjung  Kim, RPh

Roles and Responsibilities of Safety Control Manager in Korea

Moonjung Kim, RPh

Korea Institute of Drug Safety and Risk Management, Korea, Republic of

Director

Heather  Yoo, MPharm, RPh

Overview of Local QPPV requirements in Asia Pacific

Heather Yoo, MPharm, RPh

Bristol-Myers Squibb, Singapore

Head of Patient Safety, South East Asia

Sophie  Fontez

Overview of Local QPPV requirements in Asia Pacific

Sophie Fontez

-Pacific), CSL Behring, Australia

Director, Global Clinical Safety and Pharmacovigilance (GCSP) Regions Lead (Asia

Nadjat  LOUMI-MEDEDJEL

Middle East and North Africa: Regulators Introduction from Algeria, Iraq, Kuwait

Nadjat LOUMI-MEDEDJEL

Centre National De Pharmacovigilance et De Matériovigilance (CNPM), Algeria

Responsible for Training of Healthcare Professionals and Staff

Manal  Younus

Middle East and North Africa: Regulators Introduction from Algeria, Iraq, Kuwait

Manal Younus

Ministry of Health, Iraq

Head of Iraqi Pharmacovigilance Centre, Directorate of Technical Affairs

Reem   El Essa

Middle East and North Africa: Regulators Introduction from Algeria, Iraq, Kuwait

Reem El Essa

Administration, Pharmacovigilance Focal Point in Kuwait Drug and Food Control, Kuwait

Senior Pharmacy Specialist and Inspector Pharmacist at Drug Inspection

Shahinaz  Badr

Updates from MENA Region

Shahinaz Badr

Pharma Quality Europe, United Arab Emirates

Pharmacovigilance Consultant and PVQA Auditor - EMEA

Ana Paula  Goncalvez

Discussion covering Latin America (Brazil)

Ana Paula Goncalvez

Bristol-Myers Squibb , Brazil

Head of Patient Safety, Brazil

Olga  Ermishina, MD

Presentation covering Eurasia

Olga Ermishina, MD

Bayer, Russian Federation

Pharmacovigilance Country Head, Qualified Person for Pharmacovigilance in EAEU

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.